Nuffield Department of Population Health

Nuffield Department of Population Health | University of Oxford | Tweets about health, our research and impact.

Oxford
Joined on February 28, 2014
Statistics

We looked inside some of the tweets by @Oxford_NDPH and here's what we found interesting.

Inside 100 Tweets

Time between tweets:
a day
Average replies
2
Average retweets
17
Average likes
31
Tweets with photos
50 / 100
Tweets with videos
10 / 100
Tweets with links
0 / 100
Starting to smoke before the age of 15 doubles the risk of premature death.

"Millions who began smoking in childhood will die prematurely from tobacco, unless they stop"
💬 Professor Sarah Lewington

Read the full story 👉https://t.co/WddkOL01Do

#WorldLungDay https://t.co/qAeS1hYzfm

Starting to smoke before the age of 15 doubles the risk of premature death. "Millions who began smoking in childhood will die prematurely from tobacco, unless they stop" 💬 Professor Sarah Lewington Read the full story 👉https://t.co/WddkOL01Do #WorldLungDay https://t.co/qAeS1hYzfm

Controlling growth factor IGF-1 through lifestyle interventions could be an effective preventative measure for several types of #cancer

Read more 👉 https://t.co/P3jIYFSpUd 

#WorldCancerResearchDay

@OxfordMedSci @CR_UK @uk_biobank https://t.co/OfydNedjV1

Controlling growth factor IGF-1 through lifestyle interventions could be an effective preventative measure for several types of #cancer Read more 👉 https://t.co/P3jIYFSpUd #WorldCancerResearchDay @OxfordMedSci @CR_UK @uk_biobank https://t.co/OfydNedjV1

We are looking for a part-time research assistant with us at the @Ethox_Centre (@Oxford_NDPH). The RA will support REACH's survey of researchers engaged in research with vulnerable populations of women & children. All the details here: https://t.co/QqvTLe4UMw

Our paper on potential novel biochemical factors for prostate cancer incidence and mortality in @uk_biobank is now out! @BrJCancer Thanks to all my colleagues at @Oxford_NDPH and to @MiekeVHR @richard36418277 for helping me with this work! 👇 https://t.co/fXiw00PIYW

Interested in studying population health @Oxford_NDPH? Want to find out what it's really like? Meet the NDPH Student/Alumni Ambassadors! 👋 Read more ⬇️ https://t.co/S3WHU2Kx4V

How did the #RECOVERYtrial use smart trial design and tap into existing health datasets to become the most successful trial in #COVID19 to date? 👉 https://t.co/Xjgc4gr1mC @HDR_UK @NHSDigital #NHSDigitrials @OxfordBRC https://t.co/XpudWo0BAV

NEWS: #RECOVERYTrial to evaluate @Regeneron's REGN-COV2 investigational antibody cocktail as a treatment for hospitalised patients with #COVID19 https://t.co/xjf78qFpby

Postdoc position available to apply big data methods to schistosomiasis field epidemiology. Join our interdisciplinary team to address multimorbidity & transmission in East Africa to #beatNTDs! Please retweet! @Oxford_NDPH @bdi_oxford https://t.co/VHeCx5Hqof https://t.co/GMvWgV3ZOe

Postdoc position available to apply big data methods to schistosomiasis field epidemiology. Join our interdisciplinary team to address multimorbidity & transmission in East Africa to #beatNTDs! Please retweet! @Oxford_NDPH @bdi_oxford https://t.co/VHeCx5Hqof https://t.co/GMvWgV3ZOe

Our study using @uk_biobank data investigates association between IGF-1 and risks of 30 cancers. Positive associations with thyroid, colorectal, breast &prostate cancer; inverse associations with liver &ovarian cancer->likely reverse causality @Oxford_NDPH https://t.co/7CJlZrFj5O

NEWS: Study of almost 400,000 confirms that higher blood levels of IGF-1 are a risk factor for several types of #cancer

Read more ➡️ https://t.co/P3jIYFSpUd

@OxfordMedSci @CR_UK @The_MRC @wellcometrust @uk_biobank https://t.co/2xiafJck9J

NEWS: Study of almost 400,000 confirms that higher blood levels of IGF-1 are a risk factor for several types of #cancer Read more ➡️ https://t.co/P3jIYFSpUd @OxfordMedSci @CR_UK @The_MRC @wellcometrust @uk_biobank https://t.co/2xiafJck9J

New antibody treatment to be trialled on coronavirus patients in UK hospitals https://t.co/4ccyKyvE1m

Delighted that the #RECOVERYtrial will evaluate the anti-viral antibody cocktail, REGN-COV, in hospitalised patients with #COVID. This new drug specifically targets SARS-CoV-2 reducing its ability to enter cells, replicate & cause lung damage. @Regeneron https://t.co/qeELglcE7Q

The NIHR & UKRI funded RECOVERY trial has announced the inclusion of a new investigational antiviral antibody treatment, REGN-COV2 - the first specifically designed COVID-19 drug to be assessed through this flagship treatment trial https://t.co/VOpPMG7TOU @UKRI_News @Oxford_NDPH https://t.co/TXmN6JwR9S

#Breaking: Our investigational #COVID19 anti-viral antibody cocktail will be evaluated as part of the @UniofOxford Phase 3 RECOVERY trial: https://t.co/nilVh0LZVR https://t.co/swaGGtwQZm

#Breaking: Our investigational #COVID19 anti-viral antibody cocktail will be evaluated as part of the @UniofOxford Phase 3 RECOVERY trial: https://t.co/nilVh0LZVR https://t.co/swaGGtwQZm

NEWS: #RECOVERYTrial to evaluate @Regeneron's REGN-COV2 investigational antibody cocktail as a treatment for #COVID19

Read more 👉 https://t.co/hxyZOffLWF https://t.co/g7xer44bJn

NEWS: #RECOVERYTrial to evaluate @Regeneron's REGN-COV2 investigational antibody cocktail as a treatment for #COVID19 Read more 👉 https://t.co/hxyZOffLWF https://t.co/g7xer44bJn

HERC
17 days ago

ONLINE HERC COURSE: BOOKINGS OPEN We are now offering our popular course, Applied Methods of Cost-Effectiveness Analysis, online, during the week commencing 16th November 2020. For more information and to register, please visit https://t.co/RO86xZYAUI #healtheconomics

We’re looking for people to take part in a short film to explain scientific methods of #clinicaltrials 🎬

We’re particularly interested in hearing from you if you’re Black, Asian or from another ethnic minority

Please get in touch via twitter or communications@ndph.ox.ac.uk https://t.co/AlTw8jsGvR

We’re looking for people to take part in a short film to explain scientific methods of #clinicaltrials 🎬 We’re particularly interested in hearing from you if you’re Black, Asian or from another ethnic minority Please get in touch via twitter or communications@ndph.ox.ac.uk https://t.co/AlTw8jsGvR

Who will get the #CovidVaccine first? @HERC_Oxford researchers have developed a comprehensive framework to help governments distribute a vaccine effectively and fairly

Read more 👉 https://t.co/oTF0xaqOzQ https://t.co/X6BIKXsDNQ

Who will get the #CovidVaccine first? @HERC_Oxford researchers have developed a comprehensive framework to help governments distribute a vaccine effectively and fairly Read more 👉 https://t.co/oTF0xaqOzQ https://t.co/X6BIKXsDNQ

Have you ever taken part in a #ClinicalTrial? Would you like to help us explain scientific methods in a short film? 🎬

If yes, please get in touch via twitter or communications@ndph.ox.ac.uk 

We'd particularly like to hear from you if the trial was on statins https://t.co/Gi4nYMGtFI

Have you ever taken part in a #ClinicalTrial? Would you like to help us explain scientific methods in a short film? 🎬 If yes, please get in touch via twitter or communications@ndph.ox.ac.uk We'd particularly like to hear from you if the trial was on statins https://t.co/Gi4nYMGtFI

Next Page